معرفی
Joakim Bergström serves as an Associate Researcher at Uppsala University's Department of Public Health and Care Sciences within the Faculty of Medicine, specifically at the Molecular Geriatrics/Rudbeck Laboratory. He concurrently holds a Research Advisor position at the University Administration's Office of Medicine and Pharmacy.
- Faculty of Medicine, Uppsala University
- Department of Public Health and Care Sciences
- Molecular Geriatrics/Rudbeck Laboratory
- Office of Medicine and Pharmacy (Research Support Unit)
His primary research focuses on alpha-synuclein pathology mechanisms in Parkinson's disease, with particular emphasis on oligomer formation, propagation pathways, and immunotherapeutic interventions. Bergström investigates how alpha-synuclein aggregates interact with cellular components like SNARE proteins and glial cells, and develops antibody-based strategies to mitigate neurodegeneration in transgenic models.
Analysis of his 15 most recent publications reveals consistent investigation of alpha-synuclein oligomerization mechanisms, transgenic mouse modeling of Parkinson's symptoms, and therapeutic antibody development. His work spans molecular neuroscience, neuroimmunology, and translational neuropharmacology, with increasing focus on imaging techniques and cross-amyloid interactions in recent years.
Bergström actively collaborates with leading researchers in the field including Martin Ingelsson, Veronica Lindström, and Gunilla Westermark, contributing to studies that bridge basic molecular mechanisms with potential clinical applications for synucleinopathies.
